Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of ReciGen and Rebif in Relapsing Multiple Sclerosis
IRCT201112201859N3Phase 3Completed
- Sponsor
- CinnaGen
- Start
- Mar 2008
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of interferon beta-1a in multiple sclerosis (MS) (2 arms), sponsored by CinnaGen. Started Mar 2008; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT201112201859N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201112201859N3.